Home › Kanser sa Suso › Missouri

Pag-aaral pangklinika para sa Kanser sa Suso sa Missouri

75 pag-aaral para sa Kanser sa Suso ang naghahanap ng mga kalahok sa mga site sa Missouri.

Mga Lungsod sa Missouri

Opisyal na teksto ng pag-aaral (English)

The Vanguard Study: Testing a New Way to Screen for Cancer

Saint Luke's Hospital of Kansas City, Kansas City
Washington University School of Medicine, St Louis

Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo

Edad 45 hanggang 75 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT06995898

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

Washington University School of Medicine- Siteman Cancer Center, St Louis

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT06982521

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

HCA Midwest Division, Kansas City

Nagre-recruitPhase 3

Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05827081

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Mercy Oncology and Hematology - Clayton-Clarkson, Ballwin
Central Care Cancer Center - Bolivar, Bolivar
Cox Cancer Center Branson, Branson
at 21 pa

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo

Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05334069

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Washington University, School of Medicine, St Louis

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06172478

A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer

Missouri Cancer Associates, Columbia
Saint Luke's Cancer Institute, Kansas City
Oncology Hematology Associates, Springfield
at 1 pa

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06369285

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

St. Lukes Hospital of Kansas City, Kansas City
Washington University School of Medicine, St Louis

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06625775

An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors

Washington University in St Louis, St Louis

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07222267

A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

Saint Luke's Cancer Institute ( Site 0027), Kansas City
Washington University School of Medicine ( Site 0076), St Louis

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06312176

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

Research Site, St Louis

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06103864

ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

Washington University School of Medicine- Siteman Cancer Center, St Louis

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07007559

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Saint Luke's Cancer Institute ( Site 0059), Kansas City
Washington University Siteman Cancer Center ( Site 0031), St Louis

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06966700

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

Local Institution - 0140, St Louis

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT06618287

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

Mercy Health - Sindelar Cancer Center, St Louis
Mercy Health - Pratt Cancer Center, St Louis

Nagre-recruit

Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07214532

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

Clinical Trial Site, Kansas City

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07085767

Cognitive Rehabilitation Following Breast Cancer Treatment

University of Missouri, Columbia

Nagre-recruit

Edad 20 hanggang 75 · Kababaihan · Na-update Set 22, 2026 · NCT06545045

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

Washington University, St Louis

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07114601

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

Washington University School of Medicine in St. Louis, St Louis

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07213791

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Saint Luke's Cancer Institute, Kansas City
Oncology Hematology Associates, Springfield

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07174336

A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer

Washington University School of Medicine, St Louis

Nagre-recruitPhase 2

Edad 18 pataas · Kababaihan · Na-update Set 22, 2026 · NCT07287098

A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer

Saint Luke's Hospital of Kansas City, Kansas City
Washington University School of Medicine, St Louis

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT06827236

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

Saint Luke's Hospital of Kansas City, Kansas City

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07173751

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

Washington Univ. School of Medicine, St Louis

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07109726

Precision Supplemental Imaging in Women With Dense Breasts

Washington University School of Medicine, St Louis

Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo

Edad 25 hanggang 55 · Kababaihan · Na-update Set 16, 2026 · NCT07277738

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

Siteman Cancer Center, St Louis

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT06492616

A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies

Research Site, St Louis

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT05123482

A Phase 1/1b Study of IAM1363 in HER2 Cancers

Saint Luke's Cancer Institute, Kansas City
Washington University School of Medicine, St Louis

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT06253871

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

Washington University School of Medicine, St Louis

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT06440005

A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors

Washington University Medical School, St Louis

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT05307705

A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer

Washington University Siteman Cancer Center, St Louis

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT07100106

To Study the Effect of Inavolisib in Combination With Fulvestrant in Participants With Breast Cancer

HCA Midwest Division, Kansas City

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 4, 2026 · NCT07368998

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

HCA Midwest Health, Kansas City

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06790693

Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies

Oncology Hematology Associates, Springfield

Nagre-recruitObservasyonal na pag-aaral

Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07211178

Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women

Washington University School of Medicine, St Louis

Nagre-recruitObservasyonal na pag-aaral

Edad 18 hanggang 50 · Kababaihan · Na-update Set 2, 2026 · NCT06904365

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Mercy Oncology and Hematology - Clayton-Clarkson, Ballwin
Central Care Cancer Center - Bolivar, Bolivar
Cox Cancer Center Branson, Branson
at 29 pa

Nagre-recruitPhase 3

Edad 18 hanggang 60 · Kababaihan · Na-update Set 2, 2026 · NCT05879926

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

Washington University, St Louis

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT07029399

Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors

WA Uni School Of Med, St Louis

Nagre-recruitPhase 1/2

Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Ago 27, 2026 · NCT06726148

A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors

Washington University School of Medicine - Siteman Cancer Center, St Louis

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 26, 2026 · NCT07383506

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

Washington University, Siteman Cancer Center, St Louis

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 21, 2026 · NCT06774963

Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry

Universtiy Health, Kansas City
KCCC South, Kansas City
Research Medical Center, Kansas City
at 2 pa

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo

Lahat ng edad · Lahat ng kasarian · Na-update Ago 18, 2026 · NCT02302742

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.